Zinc is an early-stage mission-driven investor and the Dunhill Medical Trust is an investor in the Zinc 2 Fund.
Zinc brings together commercial experts and researchers with existing research or IP to co-found ventures solving pressing issues in the health of people and the planet.
For researchers and academics who have developed innovative deep tech or science with the potential for high impact in these mission areas, they can offer up to £300k in funding, access to their venture-building platform and ecosystem of experts and coaches to facilitate their journey to pre-seed investment readiness.
Interested? Their workshops outline different routes to commercialisation for academics, highlighting the skills and techniques needed to create impactful commercial outcomes.
Pathways to Research Commercialisation
Date: Bi-weekly on Thursdays
Time: 12:30-13:30 GMT
Sign up here: Pathways to Research Commercialisation
Prototyping Problems: Taking an Entrepreneurial Approach to Research
Date: Bi-weekly on Thursdays
Time: 13:00-14:00